The Drugs (Control) Ordinance of 1982 establishes controls on the manufacture, import, distribution and sale of drugs in Bangladesh. It creates a Drugs Control Committee to regulate drug registration and recommend cancellations. It also prohibits the manufacture, import or sale of drugs listed in three schedules, restricts the import of pharmaceutical raw materials without approval, and fixes maximum prices for drugs and raw materials. Violations of the ordinance, such as manufacturing or selling unregistered, adulterated or counterfeit drugs, are punishable by imprisonment and fines.
Drug distribution is one of the basic service provided by the hospital pharmacy.
Drug distribution system falls in to 3 categories -
1)Ward – controlled system
2)Pharmacy controlled imprest based system
3)Pharmacy controlled patient issue system
Drug distribution is one of the basic service provided by the hospital pharmacy.
Drug distribution system falls in to 3 categories -
1)Ward – controlled system
2)Pharmacy controlled imprest based system
3)Pharmacy controlled patient issue system
The government has notified the DPCO 2013 under the Essential Commodities Act, 1955, which will give power to the NPPA (National Pharmaceutical Pricing Authority (NPPA )to regulate prices of 348 essential drugs along with their specified strengths and dosages under NLEM 2011.
Most important questions of Pharmaceutical JurisprudencePayaamvohra1
This video gives an idea about frequently and most asked questions of B pharmacy Sem 5 Industrial Pharmacy
## SEm5 #PCI syllabus #Third year B pharmacy
A presentation aimed at providing information with regards to the Pharmacy Act, 1948.
-INTRODUCTION
-HISTORY OF THE ACT
-PHARMACY COUNCIL OF INDIA
-STATE PHARMACY COUNCIL
-SPECIAL PROVISIONS OF THE ACT
-OFFENCES AND PENALTIES
-CONCLUSION
-REFERENCES
Guideline for application and grant of manufacturing and selling of pharmaceutical drugs , cosmetics, biologics and medical devices to be followed by pharmaceutical industry.
DRUG INFORMATION SERVICE AND DRUG INFORMATION BULLETINSHIVANEE VYAS
"Drug information center is one of the departments of the hospital and gives the recent knowledge and information about the medical, pharmacy field at any time to the physicians, staff of the hospital and to the citizens”.
At the end of the 19th century and early 20 century use of Allopathy system increases
Drugs of natural origin: Veg, mineral oil and animals
At that time, profit became main motive than service
Overdose of quinine.A Central law to control drugs and pharmacy profession.
This presentation includes an brief idea about the pharmacy act 1948 in India and also deals with its the chapter that included in the act.(Education Regulations, PCI, State PCI, Registration of Pharmacist , Approval of Institutions, Offences penalties etc.)
bonded manufacture“ means the premises or any part of the premises approved and licensed for the manufacture and storage of medicinal and toilet preparations containing alcohol, opium, Indian hemp and other narcotic drugs or narcotics on which duty has not been paid.
Topic cover int his presentation:
1-Structure of Bonded laboratory.
2- Manufacturing procedure.
3- Storage of finished product
4- Sampling of finished goods and medicine
5- Important facts.
National Pharmaceutical Pricing AuthorityP.N.DESHMUKH
National Pharmaceutical Pricing Authority established by the central government on dated 29 th August 1997 as an independent, autonomous regulator.
Drugs Price Control Order,2013 explained Retail Prices of a scheduled Formulation,Ceiling price of a scheduled formulation,Pharmaceutical
Policy 2002,and National List of Essential Medicines (NLEM).
Drugs and Cosmetics Act, 1940 and its rules 1945:
Objectives, Definitions, Legal definitions of schedules to the Act and
Rules
Import of drugs – Classes of drugs and cosmetics prohibited from import, Import under
license or permit. Offences and penalties.
Manufacture of drugs – Prohibition of manufacture and sale of certain drugs,
Conditions for grant of license and conditions of license for manufacture of drugs,
Manufacture of drugs for test, examination and analysis, manufacture of new drug, loan
license and repacking license.
The government has notified the DPCO 2013 under the Essential Commodities Act, 1955, which will give power to the NPPA (National Pharmaceutical Pricing Authority (NPPA )to regulate prices of 348 essential drugs along with their specified strengths and dosages under NLEM 2011.
Most important questions of Pharmaceutical JurisprudencePayaamvohra1
This video gives an idea about frequently and most asked questions of B pharmacy Sem 5 Industrial Pharmacy
## SEm5 #PCI syllabus #Third year B pharmacy
A presentation aimed at providing information with regards to the Pharmacy Act, 1948.
-INTRODUCTION
-HISTORY OF THE ACT
-PHARMACY COUNCIL OF INDIA
-STATE PHARMACY COUNCIL
-SPECIAL PROVISIONS OF THE ACT
-OFFENCES AND PENALTIES
-CONCLUSION
-REFERENCES
Guideline for application and grant of manufacturing and selling of pharmaceutical drugs , cosmetics, biologics and medical devices to be followed by pharmaceutical industry.
DRUG INFORMATION SERVICE AND DRUG INFORMATION BULLETINSHIVANEE VYAS
"Drug information center is one of the departments of the hospital and gives the recent knowledge and information about the medical, pharmacy field at any time to the physicians, staff of the hospital and to the citizens”.
At the end of the 19th century and early 20 century use of Allopathy system increases
Drugs of natural origin: Veg, mineral oil and animals
At that time, profit became main motive than service
Overdose of quinine.A Central law to control drugs and pharmacy profession.
This presentation includes an brief idea about the pharmacy act 1948 in India and also deals with its the chapter that included in the act.(Education Regulations, PCI, State PCI, Registration of Pharmacist , Approval of Institutions, Offences penalties etc.)
bonded manufacture“ means the premises or any part of the premises approved and licensed for the manufacture and storage of medicinal and toilet preparations containing alcohol, opium, Indian hemp and other narcotic drugs or narcotics on which duty has not been paid.
Topic cover int his presentation:
1-Structure of Bonded laboratory.
2- Manufacturing procedure.
3- Storage of finished product
4- Sampling of finished goods and medicine
5- Important facts.
National Pharmaceutical Pricing AuthorityP.N.DESHMUKH
National Pharmaceutical Pricing Authority established by the central government on dated 29 th August 1997 as an independent, autonomous regulator.
Drugs Price Control Order,2013 explained Retail Prices of a scheduled Formulation,Ceiling price of a scheduled formulation,Pharmaceutical
Policy 2002,and National List of Essential Medicines (NLEM).
Drugs and Cosmetics Act, 1940 and its rules 1945:
Objectives, Definitions, Legal definitions of schedules to the Act and
Rules
Import of drugs – Classes of drugs and cosmetics prohibited from import, Import under
license or permit. Offences and penalties.
Manufacture of drugs – Prohibition of manufacture and sale of certain drugs,
Conditions for grant of license and conditions of license for manufacture of drugs,
Manufacture of drugs for test, examination and analysis, manufacture of new drug, loan
license and repacking license.
DRUG AND COSMETIC ACT -
For more information regarding PHARMACOVIGILANCE, CLINICAL RESEARCH, CLINICAL DATA MANAGEMENT & DRUG REGULATORY AFFAIRS kindly contact us on 9028839789
These presentation describes the rules and regulations for the manufacture of drugs and grant of license. Loan License and Repacking License is also described. These presentation is the part of series Drugs & Cosmetics Act.
This presentation consists of detailed rules and regulations related to the sales of drugs under the Drugs & Cosmetics Act. This covers the requirements for wholesale, retail, and restricted licenses.
Drug and magic remedies (objectionable advertisement) act 1954 and rules 1955Dr. Ambekar Abdul Wahid
Definitions, Class of Prohibitions Advertisement - Section 3, Classes of exempted advertisements, Powers of entry, search etc., Offenses and penalties, Scrutiny of misleading advertisements relating to drugs, Manner in which advertisements may be sent confidentially, Case Studies.
Laws Regulating Drugs and Medical DevicesAshish vishal
This is the umbrella legislation which deals with regulation of drugs and medical devices in India. It is from Section 12 of this Act that the Central Government derives the power to make rules and as a result the Drugs and Cosmetics Rules, 1945 were formulated. https://www.rickychopra.co/
Laws regulating drugs and medical devices Ashish vishal
India has the 4th largest market for drugs and medical devices in Asia. The industry has been predicted to grow to be a $ 50 billion industry in less than 5 years by 2025.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
2. Introduction
• The ordinance is to control manufacture, import, distribution and sale of drugs.
• It is the Ordinance No. VIII of 1982.
• And Published in the Bangladesh Gazette, Extraordinary, dated the 12th June,
1982.
3. 1. Short title
• This Ordinance may be called the Drugs (Control) Ordinance, 1982.
4. 2. Application of other Laws, etc.
• The provisions of this Ordinance shall be in addition to, and not in
derogation of, the Drugs Act, 1940 (XXIII of 1940) and any other law
for the time being in force that contained in that Act or in any such law
or in any contract, agreement or document.
5. 3. Definitions
(1)
a) "Act" means the Drugs Act, 1940 (XXIII of 1940).
b) "Committee" means the Drugs Control Committee constituted under this Ordinance.
c) "Council" means the National Drugs Advisory Council constituted under this
Ordinance.
d) "Drug" shall have the same meaning as in the Act and shall also include any substance
exclusively used or prepared for use in accordance with the ayurvedic, unani and
homeopathic or biochemical system of medicine.
e) "Schedule" means Schedule to this Ordinance.
(2)
Words and expressions used but not defined in this Ordinance shall have the same meaning
as in the Act.
6. 4. Drug Control Committee
1. The Government shall constitute a Drug Control Committee
consisting of a Chairman and such other members as it may appoint
from time to time.
2. The Committee shall perform such functions as are specified in this
Ordinance.
7. 5. Registration of Medicines
1. No medicine of any kind shall be manufactured for sale or be imported,
distributed or sold unless it is registered with the licencing authority.
2. The licencing authority shall not register a medicine unless such registration is
recommended by the Committee.
3. A registration shall be granted on such conditions as may be specified by the
licencing authority.
4. A registration shall, unless cancelled earlier, be valid for a period of five years.
8. 6. Cancellation or suspension of registration
1. The licencing authority may cancel the registration of any medicine if the Committee
recommends such cancellation.
2. The Committee shall evaluate every medicine registered before the commencement of
this Ordinance and every medicine that may be manufactured or imported after such
commencement in order to determine its safety, efficacy and usefulness.
3. If on such evaluation the Committee finds that any such medicine is not sale,
efficacious or useful it may recommend to the licencing authority cancellation of
registration of the medicine.
4. The licencing authority may, if it is satisfied that a medicine is substandard, suspend
the registration of such medicine till he is satisfied that the medicine has attained its
standard.
9. 7. Fees for registration
No registration of a medicine shall be granted unless a fee to be
determined by the Government is paid at the time of application for
registration.
10. 8. Prohibition of Manufacture, etc, of certain
medicines
1. On the commencement of this Ordinance, the registration or licence in respect
of all medicines mentioned in the Schedules shall stand cancelled, and no such
medicine shall, subject to the provisions of sub-section (2), be manufactured,
imported, distributed or sold after such commencement.
2. Notwithstanding anything contained in sub-section (1),
a) the medicines specified in Schedule I shall be destroyed within three months
from the date of commencement of this Ordinance.
11. Continue…..
b)
the medicines specified in Schedule II may be manufactured or sold for a period of
six months from the date of commencement of this Ordinance and thereafter their
manufacture and sale shall be permitted only if they are registered alter change in
their formulation in accordance with the direction of the licencing authority.
c)
the medicines specified in Schedule III may be manufactured, imported, distributed
and sold for a period of nine months after the commencement of this Ordinance, and
thereafter there shall not be any manufacture, import, distribution or sale of such
medicines.
12. 9. Restriction on import of certain pharmaceutical
raw material
1. No pharmaceutical raw material necessary for the manufacture of any medicine
specified in any of the Schedules shall be imported.
2. No drug or pharmaceutical raw material shall be imported except with the prior
approval of the licencing authority.
3. The licencing authority may award an approval under sub-section (2) on such
conditions as it deems fit to specify.
13. 10. Restriction on manufacture of certain
drugs under licence
No drug shall, alter six months from the date of commencement of this Ordinance,
be manufactured in Bangladesh under licence granted by a foreign company having
no manufacturing plant in Bangladesh if, such drug or its substitute is produced in
Bangladesh.
14. 11. Fixation of price of drugs
1. The Government may, by notification in the official Gazette, fix the maximum
price at which any medicine may be sold.
2. The Government may by notification in the official Gazette, fix the maximum
price at which any pharmaceutical raw material may be imported or sold.
15. 12. Review of certain licencing agreement
with foreign concerns
1. The Government may review any licencing agreement between a Bangladeshi
concern and a foreign concern for manufacture of any drug in Bangladesh in
order to find out if it contains any provision against the national interest.
2. If on such review the Government finds that any such provision of any such
agreement is against (he national interest, it may direct the concerns to modify
such provision.
3. If any such concern fails to comply with the direction given under subsection
(2) the manufacturing licence of such concern may be cancelled by the
Government.
16. 13. Employment of pharmacists
1. No person shall manufacture any drug except under the personal supervision of
a pharmacist registered in Register 'A' of the Pharmacy Council of Bangladesh.
Provided that this provision shall not apply to the manufacture of any drug
under the ayurvedic, unani, or homeopathic or biochemic system of medicine.
2. No person, being a retailer, shall sell any drug without the personal supervision
of a pharmacist registered in any Register of the Pharmacy Council of
Bangladesh.
Provided that this provision shall not apply to the retail sale of any drug under the
ayurvedic, unani, or homeopathic or biochemic system of medicine.
17. 14. Control of advertisement and claims in
respect of drugs
No person shall publish or take any part in the publication of any advertisement
which relates to the use of any drug or contains any claim in respect of therapies or
treatment without the prior approval of the licencing authority.
Explanation.— "Advertisement" includes any notice, circular or other document
displayed on or in any public place or public transport or published in any
newspaper or periodical and any announcement made orally or by any means of
producing or transmitting light or sound and any trade circular, insert and level.
18. 15. Good practices in the manufacturer and
quality control of drugs
1. Every manufacturer of drugs shall follow the good practices in the manufacture
and quality control of drugs recommended by the World Health Organization.
2. If any manufacturer does not follow such good practices his manufactured
licence may be cancelled or suspended.
19. 16. Penalty for manufacture, etc., of certain
drugs
Whoever manufactures, imports, distributes or sells—
a. any medicine which is not registered under this Ordinance, or
b. any medicine in contravention of the provisions of section 8, or
c. any drug which is adulterated or spurious.
shall be punishable with rigorous imprisonment for a term which may extend to ten
years, or with fine which may extend to two lac taka, or with both, and any
implements used in the manufacture or sale of such medicine or drug may, by order
of the Drug Court, be forfeited to the Government.
20. 17. Penalty for manufacture or sale of sub-
standard drugs
Whoever manufactures or sells any sub-standard drug shall be punishable
with rigorous imprisonment for a term which may extend to live years, or
with fine which may extend to one lac taka, or with both.
21. 18. Penalty for unauthorised import of drugs
Whoever imports any drug or pharmaceutical raw material without the prior
approval of the licencing authority shall be punishable with rigorous imprisonment
for a term which may extend to three years, or with fine which may extend to fifty
thousand taka, or with both and such drug or raw material may be order of the Drug
Court, be forfeited to the Government.
22. 19. Penalty for sale of medicine or import or sale
of pharmaceutical raw material at a higher price
Whoever sells any medicine or imports or sells any pharmaceutical raw material at a
price higher than the maximum price fixed by the Government under section 11
shall be punishable with rigorous imprisonment for a term which may extend to two
years, or with fine which any extend to ten thousand taka, or with both.
23. 20. Penalty for theft, etc., of Government drugs
Whoever commits theft in respect of any drug in any Government store, hospital,
clinic or health centre or sells any such drug or keeps in his possession any such
drug for sale shall be punishable with rigorous imprisonment for a term which may
extend to ten years, or with fine which may extend to two lac taka or with both.
24. 21. Penalty for illegal advertisement and claims
Whoever contravenes the provision of section 14 shall be punishable
with fine which may extend to twenty-five thousand taka.
25. 22. Cognizance of offences
Notwithstanding anything contained in the Code of Criminal Procedure, 1898 (V of
1898),
a. An offence punishable under this Ordinance shall be non-cognizable
b. No Court other than a Drug Court shall try an offence punishable under this
Ordinance
c. No Drug Court shall take cognizance of an offence punishable under this
Ordinance except on a report in writing made by the licencing authority or ;in
officer authorised by him in this behalf.
26. 23. Drug Courts
(1) The Government may, by notification in the official Gazette establish as many Drug
Courts as it considers necessary and where it establishes more than one Drug Court
shall specify in the notification the territorial limits within which each one of them
shall exercise jurisdiction under this Ordinance.
(2) A Drug Court shall consist of a person who is or has been a Sessions Judge and he shall
be appointed by the Government.
(3) A Drug Court shall sit at such place as the Government may direct.
(4) A Drug Court may pass any sentence authorized by this Ordinance and shall have all
the powers conferred by the Code of Criminal Procedure, 1898 (V of 1898), on a Court
of Session exercising original jurisdiction.
27. CONTINUE…
5. A Drug Court shall not, merely by reason of a change in its composition, be bound to
recall and rehear any witness who has given evidence, and may act on the evidence already
recorded by or produced before it.
6. A Drug Court shall, in all matters with respect to which no procedure has been prescribed
by this Ordinance, follow the procedure prescribed by the Code of Criminal Procedure,
1898 (V of 1898). for the trial of summons cases by Magistrates.
7. A Drug Court may, on application in ill is behalf being made by the prosecution. Try an
offence under this Ordinance summarily in accordance win the provisions contained in
sections 262 to 265 of the Code of Criminal Procedure, 1898 (V of 1898).
8. An appeal from the judgment of a Drug Court shall lie to the High Court Division.
28. 24. National Drug Advisory Council
1. The Government shall constitute a National Drug Advisory Council consisting of a
Chairman and such other members as it may appoint from time to lime.
2. The Council shall advise the Government on—
a. measures to be adopted for the implementation of the national drug policy that may be
adopted by the Government from time to time
b. measures for the promotion of local pharmaceutical industries and production and
supply of essential drugs for meeting the needs of the country.
c. matters relating to the import of drugs and pharmaceutical raw materials.
d. measures for the co-ordination of the activities of the various Ministries, agencies and
persons dealing with manufacture, import, distribution and sale of drugs.
29. 25. Power to make rules
The Government may, be notification in the official Gazette, make rules
for carrying out the purposes of this Ordinance.
30. The drugs control (Amendments)
Ordinance, 1982
Ordinance no. XXVIII of 1982
31. 1. Short title
This Ordinance may be called the Drugs (Control) Amendment Ordinance, 1982.
32. 2. Amendment of section 8, ordinance VIII of 1982
In the drug control ordinance VIII of 1982, hereinafter referred to as the said
ordinance in section 8, in sub section(2)
a) In clause (b) for the words six moths the word eighteen months shall be
substituted
33. 3.Substitution of section 10,ord 8 of 1982.
In the said ordinance , or section 10 the following shall be substituted, namely:-
“10. Restriction of manufacturing of certain drugs under license.- No drug shall be
manufactured in Bangladesh under license granted by a foreign company having no
manufacturing plant in Bangladesh if such or its substitute is produced in Bangladesh:
Provided that in the case of such license granted before the commencement of this
Ordinance such drug may , subject to the provisions of section 8, be manufactured till the
expiry or termination of the period of the license .”
4.Amendment of the schedules , ord 8 of 1982.- in the said ordinance.-
34. 4. Amendment of the schedules
in the said ordinance
a) In schedule 1,the entries against serial Nos. 44,102, 63, 129, 134, and 257 shall be
omitted.
b) In schedule 2, the entries against serial Nos. 3, 4, 5, 6, 11, 19 and 52 shall be omitted.
c) In schedule 3, the entries against serial Nos.29, 30, 36, 39, 45, 64, 65, 66, 67, 72, 74,
75, 77, 78, 96, 97, 189, 581, 585, 586, 587, 591, 592, 594, 668, 669, 154, 155, 160,
161, 200, 201, 209, 210, 217, 218, 253, 254, 278, 279, 299, 306, 307, 258, 315, 316,
335, 337, 341, 347, 362, 363, 371, 376, 384, 390, 405, 406, 411, 422, 456, 486, 487,
494, 507, 512, 525, 529, 532, 539, 560, 568, 569, 573, 575, 597, 598, 602, 612, 617,
619, 620, 623, 624, 633, 635, 637, 641, 658, 663, 666, 667, 689, 693, 710, 714, and
715
35. Continue…..
Of the locally manufactured drugs and 244 and 409 of the imported drugs shall be omitted
and
(d) After schedule 3, the following new schedule shall be added namely:-
Schedule 4 [see section 8(2)(d) ] of the drug ordinance, 1982